Health

For corporate venturers, is it better to invest directly from a corporation’s balance sheet or from a stand-alone fund?

Innovation seems threatening to legacy thinking in the region, preventing corporates from going into high-performance mode.

Deutsche Telekom and Salesforce-backed PerimeterX is joining forces with Human Security while M12 and Alexandria Venture Investments took part in Ozette’s $26m series A round.

Cisco Investments helped internet browser developer Island boost its series B round to $125m while Nufarm led crop protection technology producer Enko's $70m series C.

360 Security and CATL helped Hozon Auto close a $1.5bn series D while Origin Energy and Tokyo Gas backed a $550m round for Octopus Energy.

Amid a general downturn, spinouts have been faring much better than the startup world at large.

Novartis and Cigna Ventures were part of Cleerly’s $192m series C round while Aptos Labs secured $150m from investors including FTX, Circle and Jump Trading.

Launched just a year ago to build on work at Weill Cornell Medicine and New York-Presbyterian Hospital, Cleerly has now closed an oversubscribed series C round.

The dollar valuation of corporate-backed deals in the energy sector dropped sharply in Q2. Cleantech deals are the only exception.

There has never been a better time for corporates to invest in this sector, says Meghan Sharp, Global head of Decarbonization Partners.